MyAverix Finance
SHE · Healthcare
Guangdong Hybribio Biotech Co Ltd (300639)
Diagnostics & Research
Guangdong Hybribio Biotech Co Ltd (300639) is listed on SHE in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300639
Guangdong Hybribio Biotech Co Ltd (300639) — FAQ
What is 300639's P/E ratio?
The price-to-earnings (P/E) ratio for Guangdong Hybribio Biotech Co Ltd (300639) is 18.00 (data as of 2026-03-23).
Does Guangdong Hybribio Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guangdong Hybribio Biotech Co Ltd (300639). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangdong Hybribio Biotech Co Ltd in?
Guangdong Hybribio Biotech Co Ltd (300639) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 300639 listed on?
300639 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.